三愛健康集團(01889.HK)盈喜:2021年度預盈約900萬元
格隆匯3月27日丨三愛健康集團(01889.HK)公佈,集團預期截至2021年12月31日止年度將錄得毛利不少於4000萬元人民幣(單位下同),相對2020年同期則約為3100萬元;截至2021年12月31日止年度的公司擁有人應占純利將錄得約900萬元,相對2020年同期則約為600萬元。
董事會認為,截至2021年12月31日止年度毛利及公司擁有人應占純利增加的主要原因為(i)毛利率相對較高的自產醫藥產品銷售額增加;及(ii)融資租賃業務所產生利息收入增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.